• Health & Medicine

Skin and breast cancer drugs approved for NHS use in Scotland

An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland. An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.

16 May 2019

• Science & Technology
• Health & Medicine

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results. Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

15 May 2019

• Health & Medicine

Tackling side effects in head and neck cancer treatment - the end of the road for hyperbaric oxygen?

Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work? Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?

2 May 2019

• Health & Medicine

Breast cancer relapse test can predict treatment benefits, study suggests

Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests. Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests.

30 April 2019

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019

• Health & Medicine

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England. Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

12 April 2019

• Health & Medicine

Breast cancer drug combo gets initial ‘no’ for NHS in England

Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use. Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.

10 April 2019

• Health & Medicine

Immune-stimulating injection turns tumours into ‘cancer vaccine factories’ in mice

Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice. Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.

8 April 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

3 April 2019

• Health & Medicine

Lung cancer immunotherapy approved for NHS patients in England

An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer. An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.

28 March 2019

• Health & Medicine

Targeted lymphoma drug gets green light for NHS in England

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England. People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

22 March 2019